(688428)"INNOCARE PHARMA LIMITED"Report for Q3 2026
Filed with SSE · Stock code 688428 · · 11 pages · Chinese
Watch InnoCare Pharma's latest callInnocare Pharma (Shanghai:688428) Q2 2026 Earnings Call · Replay · Aug 24Read the transcript of Innocare Pharma (Shanghai:688428) Q2 2026 Earnings CallIn the deck
Earlier from InnoCare Pharma
- (688428)"INNOCARE PHARMA LIMITED"Announcement on Convening the Q3 2026 Performance Briefing
- Indicative Announcement on Change in Equity Interests of Shareholder Holding More Than 5% of the Shares Reaching 1% Threshold
- Announcement on Vesting Results for the First Vesting Period of the Reserved Grant under the 2024 STAR Market Restricted Share Incentive Plan and Listing of Shares
- InnoCare Announces Approval of Clinical Trial of Novel Bispecific ADC ICP-B381 Targeting PSMA/ STEAP1 in China
- Announcement on the Progress of Acquisition of the Remaining Equity in a Controlled Subsidiary
Follow InnoCare Pharma into a list and get an email when it puts out news.
Follow InnoCare Pharma